Efficacy of high-intensity, low-volume interval training compared to continuous aerobic training on insulin resistance, skeletal muscle structure and function in adults with metabolic syndrome: study protocol for a randomized controlled clinical trial (Intraining-MET)

Jaime Gallo-Villegas, Juan Carlos Aristizabal, Mauricio Estrada, Luis H Valbuena, Raul Narvaez-Sanchez, Jorge Osorio, Daniel C Aguirre-Acevedo, Juan C Calderón, Jaime Gallo-Villegas, Juan Carlos Aristizabal, Mauricio Estrada, Luis H Valbuena, Raul Narvaez-Sanchez, Jorge Osorio, Daniel C Aguirre-Acevedo, Juan C Calderón

Abstract

Background: Evidence of the efficacy of high-intensity, low-volume interval training (HIIT-low volume) in treating insulin resistance (IR) in patients with metabolic disorders is contradictory. In addition, it is unknown whether this effect is mediated through muscle endocrine function, which in turn depends on muscle mass and fiber type composition. Our aims were to assess the efficacy of HIIT-low volume compared to continuous aerobic exercise (CAE) in treating IR in adults with metabolic syndrome (MS) and to establish whether musclin, apelin, muscle mass and muscle composition are mediators of the effect.

Methods: This is a controlled, randomized, clinical trial using the minimization method, with blinding of those who will evaluate the outcomes and two parallel groups for the purpose of showing superiority. Sixty patients with MS and IR with ages between 40 and 60 years will be included. A clinical evaluation will be carried out, along with laboratory tests to evaluate IR (homeostatic model assessment (HOMA)), muscle endocrine function (serum levels of musclin and apelin), thigh muscle mass (by dual energy x-ray absorptiometry (DXA) and thigh muscle composition (by carnosine measurement with proton magnetic resonance spectroscopy (1H-MRS)), before and after 12 weeks of a treadmill exercise program three times a week. Participants assigned to the intervention (n = 30) will receive HIIT-low volume in 22-min sessions that will include six intervals at a load of 90% of maximum oxygen consumption (VO2 max) for 1 min followed by 2 min at 50% of VO2 max. The control group (n = 30) will receive CAE at an intensity of 60% of VO2 max for 36 min. A theoretical model based on structural equations will be proposed to estimate the total, direct and indirect effects of training on IR and the proportion explained by the mediators.

Discussion: Compared with CAE, HIIT-low volume can be effective and efficient at improving physical capacity and decreasing cardiovascular risk factors, such as IR, in patients with metabolic disorders. Studies that evaluate mediating variables of the effect of HIIT-low volume on IR, such as endocrine function and skeletal muscle structure, are necessary to understand the role of skeletal muscle in the pathophysiology of MS and their regulation by exercise.

Trial registration: NCT03087721 . High-intensity Interval, Low Volume Training in Metabolic Syndrome (Intraining-MET). Registered on 22 March 2017, retrospectively registered.

Keywords: Aerobic exercise; Exercise training; Glucose metabolism disorders; Hyperinsulinemia; Insulin resistance; Interval training; Metabolic syndrome; Myokines; Risk factors; Skeletal muscle.

Conflict of interest statement

Ethics approval and consent to participate

The Research Ethics Committee of the Faculty of Medicine at Universidad de Antioquia in Medellín approved the study protocol (minutes number 013 from 26th September 2013). The Research Ethics Committee IPS-Universitaria at Universidad de Antioquia in Medellín, Colombia approved the study protocol (minutes number 097 from 22nd June 2016). All patients will sign the informed consent to participate.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
General design of the study, schedule of enrollment, intervention and assessment*. a After signing the informed consent, the patients will undergo medical and biochemical evaluation. Once inclusion/exclusion criteria are verified, recruited patients will be evaluated for muscle mass, fiber type composition of the vastus lateralis muscle (VLM), and cardio-respiratory physical capacity. Then, patients will be assigned to a high-intensity/low-volume interval training (HIIT-low volume) or continuous aerobic exercise training (CAE) intervention. A final reevaluation will be performed. b Evaluations during both enrollment and close out periods are expected to last 2 weeks. The intervention will last 12 weeks. HOMA-IR, Homeostatic Model Assessment-Insulin Resistance; HbA1c, glycated hemoglobin; IR, insulin resistance; MS, metabolic syndrome
Fig. 2
Fig. 2
Training protocols for intervention. a High-intensity/low-volume interval training protocol scheme. b Continuous aerobic exercise protocol scheme. VO2 max, maximum oxygen consumption
Fig. 3
Fig. 3
Conceptual model for the study of the effect of high-intensity/low-volume interval training or continuous exercise training on insulin resistance in patients with metabolic syndrome. The model considers mediator variables such as musclin and apelin, muscle mass and fiber type composition in the thigh; and confounding variables such as age, gender and body mass index

References

    1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644.
    1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–1778. doi: 10.2337/diacare.28.7.1769.
    1. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106(3):286–288. doi: 10.1161/01.CIR.0000019884.36724.D9.
    1. Meigs JB, Rutter MK, Sullivan LM, et al. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30(5):1219–1225. doi: 10.2337/dc06-2484.
    1. Tjonna AE, Lee SJ, Rognmo O, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118(4):346–354. doi: 10.1161/CIRCULATIONAHA.108.772822.
    1. Jelleyman C, Yates T, O'Donovan G, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev. 2015;16(11):942–961. doi: 10.1111/obr.12317.
    1. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014;48(16):1227–1234. doi: 10.1136/bjsports-2013-092576.
    1. Centers for Disease Control and Prevention. State Indicator Report on Physical Activity, 2010. Atlanta: U.S. Department of Health and Human Services; 2010.
    1. Korkiakangas EE, Alahuhta MA, Laitinen JH. Barriers to regular exercise among adults at high risk or diagnosed with type 2 diabetes: a systematic review. Health Promot Int. 2009;24(4):416–427. doi: 10.1093/heapro/dap031.
    1. Eijsvogels TM, Molossi S, Lee DC, et al. Exercise at the extremes: the amount of exercise to reduce cardiovascular events. J Am Coll Cardiol. 2016;67(3):316–329. doi: 10.1016/j.jacc.2015.11.034.
    1. Gibala MJ, Little JP, Macdonald MJ, et al. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012;590(5):1077–1084. doi: 10.1113/jphysiol.2011.224725.
    1. Kessler HS, Sisson SB, Short KR. The potential for high-intensity interval training to reduce cardiometabolic disease risk. Sports Med. 2012;42(6):489–509. doi: 10.2165/11630910-000000000-00000.
    1. Earnest CP, Lupo M, Thibodaux J, et al. Interval training in men at risk for insulin resistance. Int J Sports Med. 2013;34(4):355–363.
    1. Mitranun W, Deerochanawong C, Tanaka H, et al. Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports. 2014;24(2):e69–e76. doi: 10.1111/sms.12112.
    1. Hollekim-Strand SM, Bjorgaas MR, Albrektsen G, et al. High-intensity interval exercise effectively improves cardiac function in patients with type 2 diabetes mellitus and diastolic dysfunction: a randomized controlled trial. J Am Coll Cardiol. 2014;64(16):1758–1760. doi: 10.1016/j.jacc.2014.07.971.
    1. Hood MS, Little JP, Tarnopolsky MA, et al. Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc. 2011;43(10):1849–1856. doi: 10.1249/MSS.0b013e3182199834.
    1. Whyte LJ, Gill JM, Cathcart AJ. Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men. Metabolism. 2010;59(10):1421–1428. doi: 10.1016/j.metabol.2010.01.002.
    1. Little JP, Gillen JB, Percival ME, et al. Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol (1985). 2011;111(6):1554–1560. doi: 10.1152/japplphysiol.00921.2011.
    1. Little JP, Safdar A, Cermak N, et al. Acute endurance exercise increases the nuclear abundance of PGC-1alpha in trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R912–R917. doi: 10.1152/ajpregu.00409.2009.
    1. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8(8):457–465. doi: 10.1038/nrendo.2012.49.
    1. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol (1985). 2003;95(4):1717–1727. doi: 10.1152/japplphysiol.00347.2003.
    1. Pedersen BK. Muscles and their myokines. J Exp Biol. 2011;214(Pt 2):337–346. doi: 10.1242/jeb.048074.
    1. Londono FJ, Calderon JC, Gallo J. Association between thigh muscle development and the metabolic syndrome in adults. Ann Nutr Metab. 2012;61(1):41–46. doi: 10.1159/000339267.
    1. Heitmann BL, Frederiksen P. Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ. 2009;339:b3292. doi: 10.1136/bmj.b3292.
    1. Tanner CJ, Barakat HA, Dohm GL, et al. Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab. 2002;282(6):E1191–6. doi: 10.1152/ajpendo.00416.2001.
    1. Yu J, Zheng J, Liu XF, et al. Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression. Braz J Med Biol Res. 2016;49(5):e5129. doi: 10.1590/1414-431X20165129.
    1. Nikseresht M, Hafezi Ahmadi MR, Hedayati M. Detraining-induced alterations in adipokines and cardiometabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men. Appl Physiol Nutr Metab. 2016;41(10):1018–1025. doi: 10.1139/apnm-2015-0693.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Gallo J, Ochoa J, Balparda J, et al. Puntos de corte del perímetro de la cintura para identificar sujetos con resistencia a la insulina en una población colombiana. Acta Med Colomb. 2013;38(3):118–126.
    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>;2-S.
    1. Ricciardi R. Sedentarism: a concept analysis. Nurs Forum. 2005;40(3):79–87. doi: 10.1111/j.1744-6198.2005.00021.x.
    1. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J. 2007;28(12):1462–1536.
    1. Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009;6(6):790–804. doi: 10.1123/jpah.6.6.790.
    1. Gomez LF, Duperly J, Lucumi DI, et al. Physical activity levels in adults living in Bogota (Colombia): prevalence and associated factors. Gac Sanit. 2005;19(3):206–213. doi: 10.1157/13075953.
    1. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi: 10.2337/diacare.27.6.1487.
    1. Visser M, Fuerst T, Lang T, et al. Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, aging, and body composition study–dual-energy X-ray absorptiometry and body composition working group. J Appl Physiol (1985). 1999;87(4):1513–1520. doi: 10.1152/jappl.1999.87.4.1513.
    1. Baguet A, Everaert I, Hespel P, et al. A new method for non-invasive estimation of human muscle fiber type composition. PLoS One. 2011;6(7):e21956. doi: 10.1371/journal.pone.0021956.
    1. Estrada M, Vega G, Reyngoudt H, et al. Intramuscular absolute carnosine quantification in young athletes by 1H-MRS using a flexible coil. Skelet Radiol. 2016;45(7):1021–1029. doi: 10.1007/s00256-016-2400-0.
    1. Matinhomaee H, Banaei J, Ali M, et al. Effects of 12-week high-intensity interval training on plasma visfatin concentration and insulin resistance in overweight men. J Exerc Sci Fit. 2014;12:20–25. doi: 10.1016/j.jesf.2014.01.001.
    1. Gallo J, Pérez-Idárraga A, Valencia K, et al. Effect of dancing and nutrition education on hemodynamic and autonomic status in adults with metabolic syndrome: a randomized controlled clinical trial. Rev Colomb Cardiol. 2016;23:467–478.
    1. Scott NW, McPherson GC, Ramsay CR, et al. The method of minimization for allocation to clinical trials. A review. Control Clin Trials. 2002;23(6):662–674. doi: 10.1016/S0197-2456(02)00242-8.
    1. Saghaei M, Saghaei S. Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials. J Biomed Sci Eng. 2011;4:734–739. doi: 10.4236/jbise.2011.411090.
    1. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–115. doi: 10.2307/2529712.
    1. Newgard CD, Haukoos JS. Advanced statistics: missing data in clinical research–part 2: multiple imputation. Acad Emerg Med. 2007;14(7):669–678.
    1. Egbewale BE, Lewis M, Sim J. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study. BMC Med Res Methodol. 2014;14:49. doi: 10.1186/1471-2288-14-49.
    1. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–1182. doi: 10.1037/0022-3514.51.6.1173.
    1. Hafeman DM, Schwartz S. Opening the black box: a motivation for the assessment of mediation. Int J Epidemiol. 2009;38(3):838–845. doi: 10.1093/ije/dyn372.
    1. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877–883. doi: 10.1001/archpsyc.59.10.877.
    1. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379–1406. doi: 10.1152/physrev.90100.2007.
    1. Nishizawa H, Matsuda M, Yamada Y, et al. Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem. 2004;279(19):19391–19395. doi: 10.1074/jbc.C400066200.
    1. Subbotina E, Sierra A, Zhu Z, et al. Musclin is an activity-stimulated myokine that enhances physical endurance. Proc Natl Acad Sci USA. 2015;112(52):16042–16047. doi: 10.1073/pnas.1514250112.
    1. Castan-Laurell I, Dray C, Knauf C, et al. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab. 2012;23(5):234–241. doi: 10.1016/j.tem.2012.02.005.
    1. Kadoglou NP, Vrabas IS, Kapelouzou A, et al. The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes. Med Sci Monit. 2012;18(5):CR290–5. doi: 10.12659/MSM.882734.
    1. Besse-Patin A, Montastier E, Vinel C, et al. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes. 2014;38(5):707–713. doi: 10.1038/ijo.2013.158.
    1. Grossman J, Payne E. A randomized comparison study regarding the impact of short-duration, high-intensity exercise and traditional exercise on anthropometric and body composition measurement changes in post-menopausal women–a pilot study. Post Reprod Health. 2016;22(1):14–19. doi: 10.1177/2053369115623899.
    1. de Courten B, Kurdiova T, de Courten MP, et al. Muscle carnosine is associated with cardiometabolic risk factors in humans. PLoS One. 2015;10(10):e0138707. doi: 10.1371/journal.pone.0138707.
    1. Parkhouse WS, McKenzie DC. Possible contribution of skeletal muscle buffers to enhanced anaerobic performance: a brief review. Med Sci Sports Exerc. 1984;16(4):328–338. doi: 10.1249/00005768-198408000-00002.
    1. Edge J, Eynon N, McKenna MJ, et al. Altering the rest interval during high-intensity interval training does not affect muscle or performance adaptations. Exp Physiol. 2013;98(2):481–490. doi: 10.1113/expphysiol.2012.067603.
    1. Richiardi L, Bellocco R, Zugna D. Mediation analysis in epidemiology: methods, interpretation and bias. Int J Epidemiol. 2013;42(5):1511–1519. doi: 10.1093/ije/dyt127.

Source: PubMed

Подписаться